
{"id":2502,"date":"2023-02-02T17:00:46","date_gmt":"2023-02-02T17:00:46","guid":{"rendered":"https:\/\/mazzistudios.com\/clientsite-pls\/?p=2502"},"modified":"2023-09-22T17:29:48","modified_gmt":"2023-09-22T17:29:48","slug":"rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/","title":{"rendered":"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine"},"content":{"rendered":"[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221; column_padding_type=&#8221;default&#8221; gradient_type=&#8221;default&#8221;][vc_column_text]<strong>Vancouver, B.C., Canada, February 2, 2023<\/strong> \u2013 Purpose Life Sciences, a high impact Clinical Research Organization, with the <a href=\"https:\/\/mazzistudios.com\/clientsite-pls\/about\/\">mission to modernize clinical trial<\/a>s on a global scale, has signed a key agreement with GreenLight Biosciences to support their Phase I clinical trial, GLB-003, for a novel mRNA vaccine against COVID-19 in Rwanda \u2013 that today has been approved by the Rwanda FDA.<\/p>\n<p>The trial will be performed by leading clinical investigators in Rwanda, in partnership with Purpose Life Sciences. Rwandan scientific leaders have conducted several clinical trials for large pharmaceutical companies and are at the forefront of advancing end-to-end research and development in Africa.<\/p>\n<p>Purpose Life Sciences has built an innovative global partnerships network for executing clinical trials with modern technology and infrastructure that has the potential to lower costs and accelerate the time to market for products. The network has expertise in COVID-19, vaccines, viral respiratory, and other infectious diseases.<\/p>\n<p>\u201cWe share a common vision with Purpose Life Sciences of working towards global vaccine self-sufficiency and look forward to using Purpose Life Sciences in the conduct of our clinical trial,\u201d said Andrey Zarur, CEO, and co-founder of <a href=\"https:\/\/www.greenlightbiosciences.com\/\" target=\"_blank\" rel=\"noopener\">GreenLight Biosciences<\/a>.<\/p>\n<p>In the last few years, global public health has been compromised by infectious diseases and outdated clinical trial practices. Purpose Life Sciences has invested in the successful development of a complex global network of community-based sites, designing a configuration and workflows with infrastructure that can assess a protocol and mobilize Phase I, II, and III trials with great efficiency. Purpose Life Sciences goes where the disease is and focuses on patient populations wherever they are located. Africa has been one of the highest economic growth regions in the world and has substantial potential for clinical research, production, and consumption \u2013 including in Rwanda.<\/p>\n<p>Purpose Life Sciences has also created a Community of Practice across its investigators and sites to ensure constant quality improvement and innovation in how to conduct trials and to maximize investigator engagement to conduct trials more rapidly and, potentially, accelerate access to life-saving products.<\/p>\n<p>\u201cWe are delighted with the approval of this trial by the Rwanda FDA. Trust, long-term relationships, and local expertise have all come together to allow us to move from protocol assessment to trial approval at due speed,\u201d said Dr. Ed Mills, founder, and Chief Science Officer of Purpose Life Sciences. \u201cWe look forward to this Phase I with GreenLight Biosciences while we are already working on large scale trials that have the potential to rapidly recruit and complete clinical trials in many thousands of participants.[\/vc_column_text][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>Purpose Life Sciences, a high impact Clinical Research Organization, with the mission to modernize clinical trials on a global scale, has signed a key agreement with GreenLight Biosciences to support their Phase I clinical trial, GLB-003, for a novel mRNA vaccine against COVID-19 in Rwanda \u2013 that today has been approved by the Rwanda FDA.<\/p>\n","protected":false},"author":18,"featured_media":2503,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[37],"tags":[],"post-month-for-search":[50],"post-year-for-search":[61],"class_list":{"0":"post-2502","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news","8":"post-month-for-search-february","9":"post-year-for-search-61"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v18.1 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine | Purpose Life Sciences<\/title>\n<meta name=\"description\" content=\"Purpose Life Sciences has signed a key agreement with GreenLight Biosciences to support their Phase I clinical trial, GLB-003.\" \/>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine\" \/>\n<meta property=\"og:description\" content=\"Purpose Life Sciences has signed a key agreement with GreenLight Biosciences to support their Phase I clinical trial, GLB-003.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"Purpose Life Sciences\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T17:00:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-22T17:29:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mazzistudios.com\/clientsite-pls\/wp-content\/uploads\/2023\/09\/Rwanda_FDA_approves_1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1128\" \/>\n\t<meta property=\"og:image:height\" content=\"632\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Purpose Life Sciences\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Purpose Life Sciences\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/\"},\"author\":{\"name\":\"Purpose Life Sciences\",\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/person\/1f160552d27a87eb0ce41037e69653f4\"},\"headline\":\"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine\",\"datePublished\":\"2023-02-02T17:00:46+00:00\",\"dateModified\":\"2023-09-22T17:29:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/\"},\"wordCount\":609,\"publisher\":{\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/\",\"url\":\"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/\",\"name\":\"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine | Purpose Life Sciences\",\"isPartOf\":{\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#website\"},\"datePublished\":\"2023-02-02T17:00:46+00:00\",\"dateModified\":\"2023-09-22T17:29:48+00:00\",\"description\":\"Purpose Life Sciences has signed a key agreement with GreenLight Biosciences to support their Phase I clinical trial, GLB-003.\",\"breadcrumb\":{\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/mazzistudios.com\/clientsite-pls\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#website\",\"url\":\"https:\/\/mazzistudios.com\/clientsite-pls\/\",\"name\":\"Purpose Life Sciences\",\"description\":\"Build a healthier world with innovative trials Platform Life Sciences redefines clinical trials by providing speed, adaptability, and global partnerships to evaluate life-saving therapeutics.\",\"publisher\":{\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mazzistudios.com\/clientsite-pls\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#organization\",\"name\":\"Purpose Life Sciences\",\"url\":\"https:\/\/mazzistudios.com\/clientsite-pls\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mazzistudios.com\/clientsite-pls\/wp-content\/uploads\/2023\/08\/Black-Purpose-Life-Sciences-Logo.png\",\"contentUrl\":\"https:\/\/mazzistudios.com\/clientsite-pls\/wp-content\/uploads\/2023\/08\/Black-Purpose-Life-Sciences-Logo.png\",\"width\":2428,\"height\":676,\"caption\":\"Purpose Life Sciences\"},\"image\":{\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/purpose-life-sciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/person\/1f160552d27a87eb0ce41037e69653f4\",\"name\":\"Purpose Life Sciences\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d0eb1704f8653edaede33e15637cbbbe2e2ee7a98d22920aea8d3b75bd31efa9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d0eb1704f8653edaede33e15637cbbbe2e2ee7a98d22920aea8d3b75bd31efa9?s=96&d=mm&r=g\",\"caption\":\"Purpose Life Sciences\"},\"url\":\"https:\/\/mazzistudios.com\/clientsite-pls\/author\/lpancoplatformlifesciences-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine | Purpose Life Sciences","description":"Purpose Life Sciences has signed a key agreement with GreenLight Biosciences to support their Phase I clinical trial, GLB-003.","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine","og_description":"Purpose Life Sciences has signed a key agreement with GreenLight Biosciences to support their Phase I clinical trial, GLB-003.","og_url":"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/","og_site_name":"Purpose Life Sciences","article_published_time":"2023-02-02T17:00:46+00:00","article_modified_time":"2023-09-22T17:29:48+00:00","og_image":[{"width":1128,"height":632,"url":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-content\/uploads\/2023\/09\/Rwanda_FDA_approves_1.jpg","type":"image\/jpeg"}],"author":"Purpose Life Sciences","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Purpose Life Sciences","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/#article","isPartOf":{"@id":"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/"},"author":{"name":"Purpose Life Sciences","@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/person\/1f160552d27a87eb0ce41037e69653f4"},"headline":"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine","datePublished":"2023-02-02T17:00:46+00:00","dateModified":"2023-09-22T17:29:48+00:00","mainEntityOfPage":{"@id":"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/"},"wordCount":609,"publisher":{"@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#organization"},"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/","url":"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/","name":"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine | Purpose Life Sciences","isPartOf":{"@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#website"},"datePublished":"2023-02-02T17:00:46+00:00","dateModified":"2023-09-22T17:29:48+00:00","description":"Purpose Life Sciences has signed a key agreement with GreenLight Biosciences to support their Phase I clinical trial, GLB-003.","breadcrumb":{"@id":"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mazzistudios.com\/clientsite-pls\/rwanda-fda-approves-purpose-life-sciences-and-greenlight-biosciences-to-launch-a-phase-i-clinical-trial-in-rwanda-for-mrna-covid-19-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mazzistudios.com\/clientsite-pls\/"},{"@type":"ListItem","position":2,"name":"Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine"}]},{"@type":"WebSite","@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#website","url":"https:\/\/mazzistudios.com\/clientsite-pls\/","name":"Purpose Life Sciences","description":"Build a healthier world with innovative trials Platform Life Sciences redefines clinical trials by providing speed, adaptability, and global partnerships to evaluate life-saving therapeutics.","publisher":{"@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mazzistudios.com\/clientsite-pls\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#organization","name":"Purpose Life Sciences","url":"https:\/\/mazzistudios.com\/clientsite-pls\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/logo\/image\/","url":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-content\/uploads\/2023\/08\/Black-Purpose-Life-Sciences-Logo.png","contentUrl":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-content\/uploads\/2023\/08\/Black-Purpose-Life-Sciences-Logo.png","width":2428,"height":676,"caption":"Purpose Life Sciences"},"image":{"@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/purpose-life-sciences\/"]},{"@type":"Person","@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/person\/1f160552d27a87eb0ce41037e69653f4","name":"Purpose Life Sciences","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mazzistudios.com\/clientsite-pls\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d0eb1704f8653edaede33e15637cbbbe2e2ee7a98d22920aea8d3b75bd31efa9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d0eb1704f8653edaede33e15637cbbbe2e2ee7a98d22920aea8d3b75bd31efa9?s=96&d=mm&r=g","caption":"Purpose Life Sciences"},"url":"https:\/\/mazzistudios.com\/clientsite-pls\/author\/lpancoplatformlifesciences-com\/"}]}},"_links":{"self":[{"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/posts\/2502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/comments?post=2502"}],"version-history":[{"count":0,"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/posts\/2502\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/media\/2503"}],"wp:attachment":[{"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/media?parent=2502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/categories?post=2502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/tags?post=2502"},{"taxonomy":"post-month-for-search","embeddable":true,"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/post-month-for-search?post=2502"},{"taxonomy":"post-year-for-search","embeddable":true,"href":"https:\/\/mazzistudios.com\/clientsite-pls\/wp-json\/wp\/v2\/post-year-for-search?post=2502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}